Jaguar Animal Health (JAGX) Enters $1M Common Stock, Warrants Private Placement
- Netflix, Inc. (NFLX) Tops Q4 EPS by 1c; Subs Beat Views
- S&P 500 ends up slightly with boost from financials; Netflix up late
- Nestle Said Examining Takeover of Mead Johnson (MJN) - Source
- La Quinta Holdings (LQ) Gains on Plan to Split in Two
- After-Hours Stock Movers 01/18: (OCLR) (CSX) (NFLX) Higher; (AMDA) (RCII) (ZYNE) Lower (more...)
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Jaguar Animal Health, Inc. (Nasdaq: JAGX) announced that it has entered into a definitive agreement to sell securities to certain institutional investors in a private placement for aggregate gross proceeds of approximately $1.0 million before deducting offering expenses payable by Jaguar. The closing is expected to occur on or about November 29, 2016 and is subject to satisfaction of customary closing conditions.
Under the terms of the offering, Jaguar will sell an aggregate of 1,666,668 shares (the “Shares”) of its common stock, par value $0.0001 (the “Common Stock”), at a price of $0.60 per share. The purchasers will also receive (i) warrants to purchase up to an aggregate of 1,666,668 shares of Common Stock at an exercise price of $0.75 per share (the “Series A Warrants”), (ii) warrants to purchase up to an aggregate of 1,666,668 shares of Common Stock at an exercise price of $0.90 per share (the “Series B Warrants”), and (iii) warrants to purchase up to an aggregate of 1,666,668 shares of Common Stock at an exercise price of $1.00 per share (the “Series C Warrants” and collectively with the Series A Warrants and the Series B Warrants, the “Warrants”). The Warrants are not exercisable until 6 months after the date of the closing. From that initial exercisable date, the Series A Warrants will have a term of 5 years, the Series B Warrants will have a term of 6 months, and the Series C Warrants will have a term of 1 year. The potential gross proceeds from the Warrants, if fully exercised on a cash basis, will be approximately $4.4 million.
The Company intends to use the proceeds from the private placement for working capital and general corporate purposes.
Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, acted as the exclusive placement agent for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uranium Energy (UEC) Increase Size and Prices $26M Offering
- Zynerba Pharma (ZYNE) Plans Offering of Common Stock
- Mallinckrodt (MNK) to Pay $100M to Settle FTC, State Charges for Violating Antitrust Laws
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings, Hot Corp. News
Related EntitiesRodman & Renshaw, H.C. Wainwright
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!